AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PPBT
  4. [6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)

[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock PPBT logo
Purple Biotech Ltd

NASDAQ:PPBT

PPBT Rankings

#6311 Ranked by Market Cap
N/A Ranked by Dividends
#5 Top Loser

PPBT Latest News

Sep 4, 2025
Purple Biotech Announces Pricing of Up To $18 Million Public Offering
Sep 4, 2025
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
Sep 3, 2025
Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2
Aug 27, 2025
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Aug 6, 2025
Purple Biotech Reports Second Quarter 2025 Financial Results

PPBT Latest SEC Filings

Sep 4, 2025
[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)
Sep 3, 2025
[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)
Aug 6, 2025
[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)
Jul 10, 2025
[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)
Jun 23, 2025
[6-K] Purple Biotech Ltd. American Current Report (Foreign Issuer)

PPBT Stock Data

5.27M
3.03M
1.89%
5.97%
Biotechnology
Healthcare
Israel
Rehovot